The impact of comorbidities on recovery following hospitalisation from COVID-19.
E. Daynes (Leicester, United Kingdom), M. Baldwin (Leicester, United Kingdom), U. Karsanji (Leicester, United Kingdom), H. Mcauley (Leicester, United Kingdom), W. Man (National Heart and Lung Institute, Imperial College, United Kingdom), R. Evans (Leicester, United Kingdom), S. Singh (Leicester, United Kingdom), +. On Behalf Of The Phosp Consortium (Leicester, United Kingdom)
Source: International Congress 2022 – Pulmonary rehabilitation and COVID-19
Session: Pulmonary rehabilitation and COVID-19
Session type: Thematic Poster
Number: 2580
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Daynes (Leicester, United Kingdom), M. Baldwin (Leicester, United Kingdom), U. Karsanji (Leicester, United Kingdom), H. Mcauley (Leicester, United Kingdom), W. Man (National Heart and Lung Institute, Imperial College, United Kingdom), R. Evans (Leicester, United Kingdom), S. Singh (Leicester, United Kingdom), +. On Behalf Of The Phosp Consortium (Leicester, United Kingdom). The impact of comorbidities on recovery following hospitalisation from COVID-19.. 2580
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|